LONA
LONA
NASDAQ · Pharmaceuticals

Leonabio Inc

$9.55
+0.73 (+8.28%)
As of May 9, 2:14 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +321.2% upside
Low Target $30.63
Average Target $40.22
High Target $46.08
Current Price $9.55
Current
$9.55
Target
$40.22
$30.63 $40.22 avg $46.08
Scenario Analysis
Bear Case
$30.63
220.7%
Low target
Base Case
$40.22
+321.2%
Avg target
Bull Case
$46.08
+382.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$14.21
-32.8% from high
52-Week Low
$2.30
+315.2% from low
Target vs 52W High
$40.22
+183.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%